文献速递中枢神经肿瘤放疗放疗物理与技术姑息放疗与转移瘤

复发脑转移瘤的挽救治疗策略与放射性坏死风险

Management approach for recurrent brain metastases following upfront radiosurgery may affect risk of subsequent radiation necrosis.
PubMed 文献 · Adv Radiat Oncol · 2016-08-24

本研究回顾性分析284例仅接受 upfront SRS 的脑转移患者,132例接受挽救治疗(44例多次),中位随访10个月,总RN率3.17%;挽救治疗未显著增加RN风险(P=.31),但挽救SRS联合WBRT组RN率显著高于其他挽救方式。

要点

  • 挽救治疗未显著增加放射性坏死风险(P=.31)。
  • 挽救SRS联合WBRT的RN率显著高于其他挽救方式。
  • WBRT剂量<30 Gy与≥30 Gy的RN率无差异。

核心结论

  • 复发脑转移瘤的初始挽救治疗策略不影响放射性坏死发生率。
  • 重复SRS联合挽救WBRT显著增加放射性坏死风险。

研究设计与样本

  • 单中心回顾性分析284例仅接受 upfront SRS 的脑转移患者。
  • 132例接受挽救治疗,44例接受多次挽救治疗。
  • 中位随访10个月。

主要发现

  • 全部患者RN率为3.17%(9/284),挽救治疗患者为4.55%(6/132),未挽救患者为1.97%(3/152)。
  • 挽救治疗未显著增加RN风险(P=.31)。
  • 挽救SRS联合WBRT组RN率为21.42%(6/28),显著高于重复SRS单独组(0/31)、WBRT单独组(0/58)、手术单独组(0/7)和手术加辅助放疗组(0/8)。
  • 挽救WBRT剂量<30 Gy与≥30 Gy的RN率无差异。
  • 多次SRS治疗中,治疗病灶数量不能预测RN发生率。

关键数值与推荐

  • RN判定基于病理确认或症状性患者中与RN一致的晚期脑影像。
  • 挽救治疗分组包括重复SRS单独、WBRT单独、SRS联合WBRT、手术单独、手术加辅助放疗。

临床怎么用

  • 复发脑转移瘤选择挽救治疗时需权衡重复SRS联合WBRT的放射性坏死风险。
  • 需改进毒性预测方法并优化挽救治疗的患者选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Many patients treated with stereotactic radiosurgery (SRS) alone as initial treatment require 1 or more subsequent salvage therapies. This study aimed to determine if commonly used salvage strategies are associated with differing risks of radiation necrosis (RN). METHODS AND MATERIALS: All patients treated with upfront SRS alone for brain metastases at our institution were retrospectively analyzed. Salvage treatment details were obtained for brain failures. Patients who underwent repeat SRS to the same lesion were excluded. RN was determined based on pathological confirmation or advanced brain imaging consistent with RN in a symptomatic patient. Patients were grouped according to salvage treatment and rates of RN were compared via Fisher's exact tests. RESULTS: Of 284 patients treated with upfront SRS alone, 132 received salvage therapy and 44 received multiple salvage treatments. This included 31 repeat SRS alone, 58 whole brain radiation therapy (WBRT) alone, 28 SRS and WBRT, 7 surgery alone, and 8 surgery with adjuvant radiation. With a median follow-up of 10 months, the rate of RN among all patients was 3.17% (9/284), salvaged patients 4.55% (6/132), and never salvaged patients 1.97% (3/152). Receiving salvage therapy did not significantly increase RN risk (P = .31). Of the patients requiring salvage treatments, the highest RN rate was among patients that had both salvage SRS and WBRT (delivered as separate salvage therapies) (6/28, 21.42%). RN rate in this group was significantly higher than in those treated with repeat SRS alone (0/31), WBRT alone (0/58), surgery alone (0/7), and surgery with adjuvant radiation (0/8). Comparing salvage WBRT doses <30 Gy versus ≥30 Gy revealed no effect of dose on RN rate. Additionally, among patients who received multiple SRS treatments, number of treated lesions was not predictive of RN incidence. CONCLUSION: Our results suggest that initial management approach for recurrent brain metastasis after upfront SRS does not affect the rate of RN. However, the risk of RN significantly increases when patients are treated with both repeat SRS and salvage WBRT. Methods to improve prediction of toxicity and optimize patient selection for salvage treatments are needed.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Rae A, Gorovets D, Rava P, et al. Management approach for recurrent brain metastases following upfront radiosurgery may affect risk of subsequent radiation necrosis. Adv Radiat Oncol. 2016. PMID: 28740900. doi:10.1016/j.adro.2016.08.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。